Table 1.
Author | Study Drug | Dose (mg/d) | N | Comparator | Dose (mg/d) | N |
Florent [24] | Lansoprazole | 30 | 60 | Omeprazole | 20 | 66 |
Witzel [25] | Pantoprazole | 40 | 163 | Omeprazole | 20 | 80 |
Dekkers [26] | Rabeprazole | 20 | 113 | Omeprazole | 20 | 114 |
Avner [12] | Lansoprazole | 15 | 68 | Placebo | 67 | |
30 | 67 | |||||
60 | 63 | |||||
Valenzuela [13] | Omeprazole | 20 40 | 202 214 | Placebo | 104 | |
Cloud [14] | Rabeprazole | 20 40 | 32 31 | Placebo | 31 | |
Humphries [27] | Rabeprazole | 20 40 | 32 31 | Placebo | 31 | |
Bardhan [15] | Lansoprazole | 30 60 | 82 85 | Ranitidine | 300 | 83 |
Michel [16] | Lansoprazole | 30 | 79 | Ranitidine | 300 | 79 |
Classen [17] | Omeprazole | 20 | 83 | Ranitidine | 300 | 74 |
Coop St Group [18] | Omeprazole | 40 | 21 | Ranitidine | 300 | 25 |
Ital Coop Grp [19] | Omeprazole | 20 | 84 | Ranitidine | 300 | 83 |
Walan [20] | Omeprazole | 20 40 | 203 194 | Ranitidine | 300 | 205 |
Choi [21] | Omeprazole | 20 | 125 | Ranitidine | 300 | 125 |
Bader [22] | Pantoprazole | 40 | 192 | Ranitidine | 300 | 123 |
Hotz [23] | Pantoprazole | 40 | 166 | Ranitidine | 300 | 82 |